Literature DB >> 33556194

SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma.

Yuepei Liang1, Yang Wang1, Wenjing Wang2, Juan Zhao2, Mian Xu2, Min Zheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33556194      PMCID： PMC7898813          DOI： 10.1111/cge.13891

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


× No keyword cloud information.
  6 in total

1.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

2.  Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.

Authors:  Kate Revill; Tim Wang; Anja Lachenmayer; Kensuke Kojima; Andrew Harrington; Jinyu Li; Yujin Hoshida; Josep M Llovet; Scott Powers
Journal:  Gastroenterology       Date:  2013-09-05       Impact factor: 22.682

3.  Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors.

Authors:  Yongjun Li; Xiaofen Ye; Jinfeng Liu; Jiping Zha; Lin Pei
Journal:  Neoplasia       Date:  2011-01       Impact factor: 5.715

4.  KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.

Authors:  Kengo Takeuchi; Young Lim Choi; Yuki Togashi; Manabu Soda; Satoko Hatano; Kentaro Inamura; Shuji Takada; Toshihide Ueno; Yoshihiro Yamashita; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Yuichi Ishikawa; Hiroyuki Mano
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

5.  Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.

Authors:  Johanna S M Mattsson; Hans Brunnström; Verena Jabs; Karolina Edlund; Karin Jirström; Stephanie Mindus; Linnéa la Fleur; Fredrik Pontén; Mats G Karlsson; Christina Karlsson; Hirsh Koyi; Eva Brandén; Johan Botling; Gisela Helenius; Patrick Micke; Maria A Svensson
Journal:  BMC Cancer       Date:  2016-08-05       Impact factor: 4.430

Review 6.  Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer.

Authors:  Stephanie M Barrows; Kelly Wright; Catherine Copley-Merriman; James A Kaye; Marc Chioda; Robin Wiltshire; Knut Martin Torgersen; Elizabeth T Masters
Journal:  Lung Cancer (Auckl)       Date:  2019-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.